Michael John McGeachie, Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Asthma | 43 | 2025 | 6291 | 3.680 |
Why?
|
MicroRNAs | 15 | 2025 | 3803 | 1.750 |
Why?
|
Adrenal Cortex Hormones | 13 | 2024 | 1886 | 1.600 |
Why?
|
Bronchodilator Agents | 5 | 2024 | 518 | 1.210 |
Why?
|
Anti-Asthmatic Agents | 6 | 2022 | 577 | 1.010 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 8 | 2025 | 3252 | 0.820 |
Why?
|
Forced Expiratory Volume | 9 | 2025 | 1831 | 0.740 |
Why?
|
Anti-Inflammatory Agents | 3 | 2020 | 1810 | 0.630 |
Why?
|
Lung | 10 | 2024 | 10101 | 0.610 |
Why?
|
Polymorphism, Single Nucleotide | 16 | 2024 | 16044 | 0.580 |
Why?
|
Administration, Inhalation | 10 | 2024 | 1169 | 0.540 |
Why?
|
Metabolomics | 8 | 2024 | 1674 | 0.510 |
Why?
|
alpha Catenin | 1 | 2015 | 37 | 0.500 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2016 | 1049 | 0.480 |
Why?
|
Semaphorins | 1 | 2015 | 96 | 0.480 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2020 | 724 | 0.470 |
Why?
|
RNA, Bacterial | 1 | 2016 | 393 | 0.450 |
Why?
|
Bayes Theorem | 5 | 2016 | 2359 | 0.440 |
Why?
|
Pharmacogenetics | 3 | 2021 | 683 | 0.440 |
Why?
|
Budesonide | 3 | 2020 | 162 | 0.420 |
Why?
|
Child | 30 | 2025 | 80917 | 0.400 |
Why?
|
Genomics | 3 | 2023 | 5926 | 0.400 |
Why?
|
Respiratory Function Tests | 7 | 2023 | 1695 | 0.370 |
Why?
|
Costa Rica | 4 | 2025 | 186 | 0.360 |
Why?
|
Genome | 2 | 2016 | 1754 | 0.360 |
Why?
|
Genetic Predisposition to Disease | 7 | 2021 | 18065 | 0.350 |
Why?
|
Receptors, Glucocorticoid | 1 | 2012 | 309 | 0.340 |
Why?
|
Multifactorial Inheritance | 3 | 2016 | 1422 | 0.330 |
Why?
|
Phenotype | 8 | 2023 | 16726 | 0.320 |
Why?
|
Gene Expression Profiling | 7 | 2024 | 9540 | 0.310 |
Why?
|
Gene Expression Regulation | 5 | 2024 | 11930 | 0.310 |
Why?
|
Bacteria | 2 | 2016 | 2216 | 0.300 |
Why?
|
Nedocromil | 2 | 2018 | 45 | 0.280 |
Why?
|
Vital Capacity | 3 | 2025 | 996 | 0.270 |
Why?
|
Child, Preschool | 15 | 2024 | 42669 | 0.260 |
Why?
|
Neoplasm Proteins | 1 | 2018 | 3604 | 0.250 |
Why?
|
Genome-Wide Association Study | 13 | 2024 | 12795 | 0.250 |
Why?
|
Down-Regulation | 2 | 2024 | 2939 | 0.250 |
Why?
|
Pyroglyphidae | 1 | 2024 | 92 | 0.230 |
Why?
|
Models, Cardiovascular | 1 | 2009 | 981 | 0.230 |
Why?
|
Bronchial Hyperreactivity | 2 | 2017 | 301 | 0.220 |
Why?
|
Humans | 62 | 2025 | 768171 | 0.220 |
Why?
|
Metabolome | 3 | 2024 | 1009 | 0.210 |
Why?
|
Adolescent | 15 | 2025 | 89169 | 0.200 |
Why?
|
Quantitative Trait Loci | 4 | 2015 | 2131 | 0.200 |
Why?
|
Male | 37 | 2025 | 364731 | 0.180 |
Why?
|
Female | 38 | 2025 | 397187 | 0.180 |
Why?
|
Calcinosis | 1 | 2009 | 1482 | 0.180 |
Why?
|
Antigens, Dermatophagoides | 2 | 2024 | 101 | 0.180 |
Why?
|
Software | 1 | 2014 | 4480 | 0.170 |
Why?
|
Sequence Analysis, RNA | 3 | 2016 | 2040 | 0.160 |
Why?
|
Hemolysis | 1 | 2021 | 417 | 0.160 |
Why?
|
Oligonucleotides | 1 | 2021 | 563 | 0.150 |
Why?
|
Lipid Metabolism | 2 | 2024 | 1904 | 0.150 |
Why?
|
Vitamin D | 4 | 2024 | 3311 | 0.140 |
Why?
|
Eosinophils | 1 | 2021 | 952 | 0.130 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2022 | 522 | 0.130 |
Why?
|
Models, Genetic | 3 | 2016 | 3447 | 0.130 |
Why?
|
Gene Expression | 3 | 2020 | 7601 | 0.130 |
Why?
|
Inflammation | 5 | 2024 | 10873 | 0.130 |
Why?
|
Area Under Curve | 2 | 2017 | 1643 | 0.130 |
Why?
|
Longitudinal Studies | 3 | 2016 | 14783 | 0.130 |
Why?
|
RNA, Messenger | 3 | 2023 | 12801 | 0.120 |
Why?
|
Dermatophagoides farinae | 1 | 2015 | 19 | 0.120 |
Why?
|
Genetic Association Studies | 2 | 2017 | 2744 | 0.120 |
Why?
|
Immunoglobulin E | 2 | 2023 | 1506 | 0.120 |
Why?
|
Interleukin-9 | 1 | 2015 | 62 | 0.120 |
Why?
|
Th2 Cells | 1 | 2020 | 1078 | 0.120 |
Why?
|
Critical Illness | 3 | 2018 | 2755 | 0.120 |
Why?
|
Severity of Illness Index | 2 | 2024 | 15949 | 0.120 |
Why?
|
Membrane Proteins | 2 | 2024 | 7876 | 0.120 |
Why?
|
Adult | 17 | 2025 | 223646 | 0.120 |
Why?
|
Cohort Studies | 9 | 2024 | 41753 | 0.110 |
Why?
|
Systems Biology | 1 | 2018 | 482 | 0.110 |
Why?
|
Wood | 1 | 2014 | 95 | 0.110 |
Why?
|
Atherosclerosis | 1 | 2009 | 3433 | 0.110 |
Why?
|
Normal Distribution | 1 | 2014 | 272 | 0.110 |
Why?
|
DNA, Mitochondrial | 1 | 2018 | 872 | 0.110 |
Why?
|
Lung Diseases, Interstitial | 1 | 2022 | 940 | 0.110 |
Why?
|
Immune System Diseases | 1 | 2015 | 253 | 0.110 |
Why?
|
Endophenotypes | 1 | 2015 | 259 | 0.110 |
Why?
|
Spirometry | 1 | 2016 | 929 | 0.100 |
Why?
|
Respiratory Sounds | 1 | 2017 | 702 | 0.100 |
Why?
|
Likelihood Functions | 1 | 2016 | 994 | 0.100 |
Why?
|
Genotype | 5 | 2018 | 13045 | 0.100 |
Why?
|
Cysteine Endopeptidases | 1 | 2015 | 542 | 0.100 |
Why?
|
RNA Interference | 1 | 2020 | 2832 | 0.100 |
Why?
|
Systemic Inflammatory Response Syndrome | 1 | 2017 | 621 | 0.100 |
Why?
|
Netherlands | 1 | 2016 | 2277 | 0.100 |
Why?
|
Gene Regulatory Networks | 2 | 2018 | 1752 | 0.100 |
Why?
|
Respiratory Therapy | 1 | 2012 | 125 | 0.100 |
Why?
|
RNA | 1 | 2021 | 2722 | 0.090 |
Why?
|
Vitamin D Deficiency | 2 | 2017 | 1388 | 0.090 |
Why?
|
Young Adult | 7 | 2020 | 60066 | 0.090 |
Why?
|
Computational Biology | 3 | 2014 | 3567 | 0.090 |
Why?
|
Middle Aged | 14 | 2025 | 223487 | 0.090 |
Why?
|
Intensive Care Units | 2 | 2014 | 3800 | 0.090 |
Why?
|
Dexamethasone | 1 | 2018 | 1965 | 0.090 |
Why?
|
Coronary Artery Disease | 1 | 2009 | 6568 | 0.080 |
Why?
|
Disease | 1 | 2014 | 675 | 0.080 |
Why?
|
Metabolic Diseases | 1 | 2015 | 684 | 0.080 |
Why?
|
Risk Factors | 7 | 2021 | 74944 | 0.080 |
Why?
|
Leukemia | 2 | 2014 | 1519 | 0.080 |
Why?
|
Respiratory Insufficiency | 1 | 2017 | 1240 | 0.080 |
Why?
|
Leukocytes, Mononuclear | 1 | 2015 | 1854 | 0.070 |
Why?
|
Discriminant Analysis | 2 | 2018 | 222 | 0.070 |
Why?
|
Intestines | 1 | 2016 | 1909 | 0.070 |
Why?
|
Hypersensitivity | 1 | 2016 | 1172 | 0.070 |
Why?
|
Gene Expression Regulation, Leukemic | 1 | 2011 | 658 | 0.070 |
Why?
|
Age Factors | 2 | 2020 | 18415 | 0.070 |
Why?
|
Epithelial Cells | 1 | 2018 | 3703 | 0.060 |
Why?
|
Infant | 3 | 2017 | 36535 | 0.060 |
Why?
|
Kaplan-Meier Estimate | 1 | 2016 | 6525 | 0.060 |
Why?
|
Predictive Value of Tests | 4 | 2020 | 15453 | 0.060 |
Why?
|
Cross-Sectional Studies | 2 | 2024 | 26379 | 0.060 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2017 | 2539 | 0.060 |
Why?
|
Dietary Supplements | 1 | 2017 | 3445 | 0.060 |
Why?
|
Treatment Outcome | 6 | 2020 | 65379 | 0.060 |
Why?
|
Models, Theoretical | 1 | 2016 | 3573 | 0.060 |
Why?
|
Cell Line | 1 | 2018 | 15602 | 0.060 |
Why?
|
Adrenergic beta-2 Receptor Agonists | 1 | 2024 | 110 | 0.060 |
Why?
|
Disease Progression | 2 | 2018 | 13668 | 0.050 |
Why?
|
Chemokine CCL4 | 1 | 2023 | 127 | 0.050 |
Why?
|
Pregnancy Complications | 1 | 2017 | 2973 | 0.050 |
Why?
|
Smoking | 2 | 2017 | 9092 | 0.050 |
Why?
|
Deoxyribonuclease I | 1 | 2023 | 228 | 0.050 |
Why?
|
Oligonucleotide Array Sequence Analysis | 1 | 2011 | 3806 | 0.050 |
Why?
|
Adrenal Insufficiency | 1 | 2024 | 195 | 0.050 |
Why?
|
Prognosis | 3 | 2020 | 30009 | 0.050 |
Why?
|
Sex Factors | 1 | 2016 | 10632 | 0.050 |
Why?
|
Pregnancy | 3 | 2023 | 30255 | 0.050 |
Why?
|
Internet | 1 | 2014 | 3110 | 0.050 |
Why?
|
Algorithms | 2 | 2014 | 14164 | 0.050 |
Why?
|
Adrenal Glands | 1 | 2024 | 557 | 0.050 |
Why?
|
Reproducibility of Results | 3 | 2022 | 20225 | 0.050 |
Why?
|
Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1 | 2011 | 1560 | 0.050 |
Why?
|
Smoke | 1 | 2023 | 242 | 0.050 |
Why?
|
Alleles | 3 | 2018 | 6894 | 0.050 |
Why?
|
Inflammation Mediators | 2 | 2020 | 1892 | 0.040 |
Why?
|
Hospital Mortality | 1 | 2014 | 5349 | 0.040 |
Why?
|
Hydroxymethylglutaryl-CoA Reductase Inhibitors | 1 | 2014 | 3251 | 0.040 |
Why?
|
Basophils | 1 | 2021 | 407 | 0.040 |
Why?
|
Sputum | 1 | 2021 | 517 | 0.040 |
Why?
|
Depression | 1 | 2018 | 8230 | 0.040 |
Why?
|
ADAM Proteins | 1 | 2020 | 242 | 0.040 |
Why?
|
Models, Biological | 1 | 2014 | 9497 | 0.040 |
Why?
|
Aged | 8 | 2022 | 171502 | 0.040 |
Why?
|
Clinical Trials as Topic | 1 | 2013 | 8052 | 0.030 |
Why?
|
APACHE | 1 | 2017 | 268 | 0.030 |
Why?
|
Allergens | 1 | 2024 | 1443 | 0.030 |
Why?
|
Transcription, Genetic | 1 | 2010 | 7609 | 0.030 |
Why?
|
Case-Control Studies | 3 | 2020 | 22290 | 0.030 |
Why?
|
Placebo Effect | 1 | 2020 | 517 | 0.030 |
Why?
|
Steroids | 1 | 2021 | 938 | 0.030 |
Why?
|
Hydrocortisone | 1 | 2024 | 1841 | 0.030 |
Why?
|
Models, Statistical | 1 | 2011 | 5107 | 0.030 |
Why?
|
Amines | 1 | 2017 | 280 | 0.030 |
Why?
|
Eosinophil Major Basic Protein | 1 | 2015 | 14 | 0.030 |
Why?
|
Infant, Newborn | 1 | 2016 | 26421 | 0.030 |
Why?
|
Citric Acid Cycle | 1 | 2016 | 234 | 0.030 |
Why?
|
Histone Deacetylases | 1 | 2020 | 717 | 0.030 |
Why?
|
Breath Tests | 1 | 2016 | 300 | 0.030 |
Why?
|
Double-Blind Method | 2 | 2020 | 12466 | 0.030 |
Why?
|
Boston | 2 | 2018 | 9374 | 0.030 |
Why?
|
Animals | 4 | 2024 | 169285 | 0.030 |
Why?
|
RNA, Small Interfering | 1 | 2023 | 3428 | 0.030 |
Why?
|
Interleukin-5 | 1 | 2015 | 267 | 0.030 |
Why?
|
Logistic Models | 2 | 2020 | 13290 | 0.030 |
Why?
|
Puerto Rico | 1 | 2015 | 380 | 0.030 |
Why?
|
Placenta | 1 | 2023 | 1725 | 0.030 |
Why?
|
Biodiversity | 1 | 2016 | 345 | 0.030 |
Why?
|
Hep G2 Cells | 1 | 2014 | 378 | 0.030 |
Why?
|
Homozygote | 1 | 2018 | 1779 | 0.030 |
Why?
|
Chromosomes, Human, Pair 15 | 1 | 2014 | 361 | 0.030 |
Why?
|
Metabolic Networks and Pathways | 1 | 2017 | 800 | 0.030 |
Why?
|
3' Untranslated Regions | 1 | 2014 | 515 | 0.020 |
Why?
|
Principal Component Analysis | 1 | 2015 | 948 | 0.020 |
Why?
|
Proteoglycans | 1 | 2015 | 809 | 0.020 |
Why?
|
Registries | 2 | 2018 | 8375 | 0.020 |
Why?
|
Drug Therapy | 1 | 2014 | 504 | 0.020 |
Why?
|
Office Visits | 1 | 2015 | 595 | 0.020 |
Why?
|
Disease Susceptibility | 1 | 2017 | 1793 | 0.020 |
Why?
|
Neutrophils | 1 | 2023 | 3786 | 0.020 |
Why?
|
Linear Models | 1 | 2020 | 5884 | 0.020 |
Why?
|
Community-Acquired Infections | 1 | 2014 | 472 | 0.020 |
Why?
|
Fetal Blood | 1 | 2016 | 1361 | 0.020 |
Why?
|
Linkage Disequilibrium | 1 | 2014 | 1997 | 0.020 |
Why?
|
Fatty Acids | 1 | 2017 | 1812 | 0.020 |
Why?
|
Cause of Death | 1 | 2020 | 3721 | 0.020 |
Why?
|
Genetic Linkage | 1 | 2014 | 2342 | 0.020 |
Why?
|
Vitamins | 1 | 2017 | 1638 | 0.020 |
Why?
|
Repressor Proteins | 1 | 2020 | 2982 | 0.020 |
Why?
|
Polymerase Chain Reaction | 1 | 2018 | 6082 | 0.020 |
Why?
|
Gene Frequency | 1 | 2015 | 3623 | 0.020 |
Why?
|
Breast Feeding | 1 | 2016 | 1363 | 0.020 |
Why?
|
Enhancer Elements, Genetic | 1 | 2014 | 1367 | 0.020 |
Why?
|
Cesarean Section | 1 | 2016 | 1425 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2017 | 2785 | 0.020 |
Why?
|
Follow-Up Studies | 2 | 2020 | 39354 | 0.020 |
Why?
|
Chromosome Mapping | 1 | 2014 | 4620 | 0.020 |
Why?
|
Up-Regulation | 1 | 2015 | 4149 | 0.020 |
Why?
|
Endothelial Cells | 1 | 2018 | 3589 | 0.020 |
Why?
|
Cytokines | 1 | 2020 | 7452 | 0.020 |
Why?
|
Oxidative Stress | 1 | 2016 | 3140 | 0.020 |
Why?
|
Aged, 80 and over | 1 | 2009 | 59626 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 2015 | 1947 | 0.010 |
Why?
|
DNA-Binding Proteins | 1 | 2020 | 9617 | 0.010 |
Why?
|
Risk | 1 | 2014 | 9613 | 0.010 |
Why?
|
Transcription Factors | 1 | 2020 | 12171 | 0.010 |
Why?
|
Emergency Service, Hospital | 1 | 2020 | 7951 | 0.010 |
Why?
|
Environmental Exposure | 1 | 2015 | 4543 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10840 | 0.010 |
Why?
|
Sepsis | 1 | 2014 | 2608 | 0.010 |
Why?
|
Aging | 1 | 2018 | 8743 | 0.010 |
Why?
|
Cells, Cultured | 1 | 2015 | 19025 | 0.010 |
Why?
|
Research Design | 1 | 2015 | 6209 | 0.010 |
Why?
|
Tomography, X-Ray Computed | 1 | 2022 | 20762 | 0.010 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 17142 | 0.010 |
Why?
|
Mice | 1 | 2023 | 82049 | 0.010 |
Why?
|
Genetic Variation | 1 | 2010 | 6610 | 0.010 |
Why?
|
United States | 1 | 2015 | 73039 | 0.000 |
Why?
|